A study evaluating efficacy and safety of infliximab (CT-P13) in patients with inflammatory bowel disease in real clinical practice.
Latest Information Update: 18 Feb 2019
At a glance
- Drugs Infliximab (Primary) ; Antihistamines; Corticosteroids
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- 14 Mar 2017 New trial record
- 09 Mar 2017 Preliminary results published in the Digestive Diseases and Sciences